Impact of PSMA PET/CT on Prostate Cancer Salvage Radiotherapy Management

Drs. Jérémie Calais, Amar Kishan, and Nicholas Nickols, all of the University of California, Los Angeles, highlight the importance and initial results of their prospective, multicenter, randomized phase 3 trial on the impact of PSMA PET/CT on prostate cancer salvage radiotherapy management.

They discuss what they found in terms of treatment escalation and de-escalation in the intervention versus control groups, whether the observed trends in BCR salvage radiotherapy management aligned with their initial hypotheses, and how to justify the adoption of a new test with better diagnostic accuracy when there is no evidence of its impact on patient outcomes?.

View their continued comments on Projecting Survival Data and Additional Research Avenues.